- Condition: Cystic Fibrosis
Interventions: Drug: Inhaled Vancomycin; Drug: Placebo (Sterile Water); Drug: Rifampin; Drug: Trimethoprim/Sulfamethoxazole (TMP/SMX); Drug: Doxycycline; Drug: Mupirocin Nasal Ointment; Drug: 4% chlorhexidine gluconate liquid skin cleanser
Sponsors: Johns Hopkins University; Michael Boyle; Case Western Reserve University; Cystic Fibrosis Foundation
Not yet recruiting - verified May 2012 - Condition: Tuberculosis
Intervention:
Sponsors: Cepheid; Cepheid; AIDS Clinical Trials Group; Centers for Disease Control and Prevention
Recruiting - verified April 2012 - Condition: Tuberculosis
Intervention: Drug: Rifapentine (RPT)
Sponsors: National Institute of Allergy and Infectious Diseases (NIAID); National Institute of Allergy and Infectious Diseases (NIAID)
Not yet recruiting - verified May 2012 - Condition: Dermatomyositis Associated Superficial Calcinosis
Interventions: Device: Fractional Carbon Dioxide (FCO2) Laser (Candela QuadraLase (TM)); Drug: Sodium thiosulfate
Sponsors: George Washington University; George Washington University
Not yet recruiting - verified April 2012 - Condition: Healthy
Interventions: Drug: Apremilast; Drug: Rifampin
Sponsors: Celgene Corporation; Celgene Corporation
Recruiting - verified March 2012 - Condition: Tuberculosis
Interventions: Drug: PA-824; Drug: Efavirenz (EFV); Drug: Lopinavir/Ritonavir (LPV/r); Drug: Rifampin (RIF)
Sponsors: National Institute of Allergy and Infectious Diseases (NIAID); National Institute of Allergy and Infectious Diseases (NIAID)
Not yet recruiting - verified May 2012 - Condition: Head and Neck Cancer
Interventions: Drug: Intra-arterial cisplatin; Drug: Intravenous cisplatin
Sponsors: Southern Illinois University; Southern Illinois University
Not yet recruiting - verified April 2012 - Condition: Drug Induced Constipation
Interventions: Drug: NKTR-118; Drug: Rifampin
Sponsors: AstraZeneca; AstraZeneca
Recruiting - verified March 2012 - Condition: COCAINE-RELATED DISORDERS
Interventions: Drug: d-cycloserine; Drug: sugar pill
Sponsors: Johns Hopkins University; Johns Hopkins University; National Institute on Drug Abuse (NIDA)
Recruiting - verified February 2012 - Developing Memory Reconsolidation Blockers as Novel Post-traumatic Stress Disorder (PTSD) TreatmentsCondition: Post-traumatic Stress Disorder
Interventions: Drug: Mifepristone; Drug: Cycloserine; Drug: sugar pill
Sponsors: Massachusetts General Hospital; Roger K. Pitman, MD
Recruiting - verified December 2011 - Condition: Infection
Intervention:
Sponsors: University of North Carolina, Chapel Hill; University of North Carolina, Chapel Hill; Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)
Recruiting - verified September 2011 - Condition: Tuberculosis
Intervention: Drug: Higher-Dose Rifampin
Sponsors: Harvard University Faculty of Medicine; Harvard University Faculty of Medicine; National Institute of Allergy and Infectious Diseases (NIAID); Sanofi-Aventis; Harvard School of Public Health; Brigham and Women's Hospital; University of Liverpool; Universidade Federal do Espírito Santo; Socios En Salud Sucursal Perú; St George's, University of London; University of Florida
Not yet recruiting - verified August 2011 - Conditions: Tuberculosis; HIV Infections
Interventions: Drug: Rifapentine (RPT); Drug: Isoniazid (INH); Dietary Supplement: Pyridoxine (Vitamin B6)
Sponsors: National Institute of Allergy and Infectious Diseases (NIAID); National Institute of Allergy and Infectious Diseases (NIAID)
Not yet recruiting - verified May 2012 - Condition: Obsessive-Compulsive Disorder
Interventions: Drug: D-Cycloserine; Drug: Placebo
Sponsors: Massachusetts General Hospital; Massachusetts General Hospital; National Institute of Mental Health (NIMH); University of South Florida
Recruiting - verified March 2012 - Condition: Smoking Cessation
Interventions: Drug: D-cycloserine; Drug: Placebo
Sponsors: Massachusetts General Hospital; Massachusetts General Hospital
Recruiting - verified July 2011 - Conditions: Tuberculosis, Pulmonary; Mycobacterium Tuberculous; Antitubercular Agents; Tuberculosis, Mulutidrug-Resistant; Extensively Drug-Resistant; Extensibely Drug-Resistant Tuberculosis
Intervention:
Sponsors: National Institutes of Health Clinical Center (CC); National Institute of Allergy and Infectious Diseases (NIAID)
Recruiting - verified April 2012 - Condition: Obsessive-compulsive Disorder
Interventions: Behavioral: Cognitive-behavioral therapy; Drug: d-cycloserine; Drug: Pill placebo
Sponsors: University of South Florida; University of South Florida; Massachusetts General Hospital
Recruiting - verified March 2012 - Condition: Cancer
Interventions: Procedure: Insertion of Pressure Equalization (PE) Tubes; Drug: Sodium Thiosulfate (STS); Other: Saline (Placebo); Drug: Cisplatin
Sponsors: Thomas Jefferson University; Thomas Jefferson University
Recruiting - verified January 2012 - Conditions: Cystic Fibrosis; Methicillin-resistant Staphylococcus Aureus
Interventions: Drug: Rifampin; Drug: Trimethoprim/Sulfamethoxazole; Drug: Minocycline; Drug: Mupirocin; Drug: chlorhexidine gluconate oral rinse; Drug: 2% Chlorhexidine solution wipes; Behavioral: Environmental Decontamination
Sponsors: University of North Carolina, Chapel Hill; University of North Carolina, Chapel Hill; CF Therapeutics Development Network Coordinating Center; Seattle Children's Hospital; University of Washington; University of Colorado, Denver; Texas Children's Hospital; University of Alabama at Birmingham; St. Louis Children's Hospital; Cook Children's Medical Center; University of Michigan Health System
Recruiting - verified January 2012 - Condition: Tuberculosis
Interventions: Drug: TMC207; Drug: Rifampin; Drug: Rifabutin
Sponsors: National Institute of Allergy and Infectious Diseases (NIAID); National Institute of Allergy and Infectious Diseases (NIAID)
Recruiting - verified February 2012 - Condition: Post Traumatic Stress Disorder
Interventions: Drug: DCS (D-Cycloserine ) + Prolonged Imaginal Exposure; Drug: DCS (D-Cycloserine ) + Virtual Reality Exposure; Drug: Placebo + Prolonged Imaginal Exposure; Drug: Placebo (sugar pill) + Virtual Reality Exposure
Sponsors: Weill Medical College of Cornell University; Weill Medical College of Cornell University; Department of Defense; Emory University; University of Southern California; VA Long Beach Healthcare System; National Intrepid Center of Excellence (NICoE)
Recruiting - verified March 2012 - Condition: Neoplasm Metastases
Interventions: Drug: Sequence 1; Drug: Sequence 2; Drug: Sequence 1; Drug: Sequence 2
Sponsors: Janssen Research & Development, LLC; Janssen Research & Development, LLC
Recruiting - verified May 2012 - Condition: Unspecified Adult Solid Tumor, Protocol Specific
Interventions: Drug: dextromethorphan hydrobromide; Drug: gamma-secretase/Notch signalling pathway inhibitor RO4929097; Drug: ketoconazole; Drug: midazolam hydrochloride; Drug: omeprazole; Drug: rifampin; Drug: tolbutamide
Sponsors: National Cancer Institute (NCI); University of Wisconsin, Madison; National Cancer Institute (NCI)
Recruiting - verified July 2011 - Conditions: Posttraumatic Stress Disorder; PTSD
Interventions: Drug: D-cycloserine; Drug: Placebo pill
Sponsors: Tulane University School of Medicine; Tulane University School of Medicine; National Alliance for Research on Schizophrenia and Depression
Recruiting - verified July 2010 - Conditions: Posttraumatic Stress Disorders; PTSD
Interventions: Drug: D-cycloserine; Drug: Placebo pill
Sponsors: Tulane University School of Medicine; Tulane University School of Medicine; National Institute of Mental Health (NIMH)
Recruiting - verified July 2010 - Condition: Phobic Disorders
Interventions: Behavioral: Individual Cognitive Behavioral Therapy (CBT); Drug: D-Cycloserine; Drug: Placebo
Sponsors: Southern Methodist University; Southern Methodist University
Recruiting - verified July 2011 - Conditions: Autistic Disorder; Asperger's Disorder; Pervasive Developmental Disorder NOS
Interventions: Drug: D-cycloserine; Drug: Placebo
Sponsors: Indiana University; Indiana University; Department of Defense
Recruiting - verified April 2012 - Condition: Drug Dependence
Intervention: Drug: 2-4 of the drugs listed below
Sponsors: University of Arkansas; University of Arkansas; National Institute on Drug Abuse (NIDA)
Recruiting - verified February 2012 - Condition: Height Phobia
Interventions: Behavioral: In Vivo Exposure Therapy; Behavioral: Virtual Reality Exposure Therapy; Drug: D-Cycloserine; Drug: Placebo
Sponsors: CAMC Health System; CAMC Health System; West Virginia University; University of Charleston
Recruiting - verified March 2012 - Conditions: Central Nervous System Embryonal Tumor; Germ Cell Tumors
Interventions: Drug: Melphalan; Drug: Carboplatin; Drug: Sodium thiosulfate; Drug: Filgrastim; Drug: Pegfilgrastim
Sponsors: OHSU Knight Cancer Institute; OHSU Knight Cancer Institute
Recruiting - verified January 2012 - Condition: Posttraumatic Stress Disorder
Interventions: Drug: DCS; Other: Placebo
Sponsors: Weill Medical College of Cornell University; Weill Medical College of Cornell University
Recruiting - verified December 2011 - Condition: Body Dysmorphic Disorder
Intervention: Drug: d-cycloserine
Sponsors: Massachusetts General Hospital; Massachusetts General Hospital
Recruiting - verified January 2012 - Condition: Cocaine Use Disorders
Intervention: Drug: cycloserine
Sponsors: Medical University of South Carolina; Medical University of South Carolina; National Institute on Drug Abuse (NIDA)
Recruiting - verified June 2011 - Conditions: Brain and Central Nervous System Tumors; Childhood Germ Cell Tumor; Extragonadal Germ Cell Tumor; Liver Cancer; Neuroblastoma; Ototoxicity; Ovarian Cancer; Sarcoma
Interventions: Drug: sodium thiosulfate; Procedure: examination
Sponsors: National Cancer Institute (NCI); Children's Oncology Group; National Cancer Institute (NCI)
Recruiting - verified May 2012 - Condition: Pulmonary Tuberculosis
Interventions: Drug: rifampin; Drug: rifapentine; Drug: rifapentine; Drug: rifapentine
Sponsors: Centers for Disease Control and Prevention; Centers for Disease Control and Prevention; Sanofi-Aventis
Recruiting - verified May 2012 - Condition: Posttraumatic Stress Disorder
Interventions: Drug: D-Cycloserine; Other: placebo
Sponsors: Weill Medical College of Cornell University; Weill Medical College of Cornell University
Recruiting - verified December 2011 - Conditions: Systemic Anaplastic Large-Cell Lymphoma; Neoplasms; Anaplastic Lymphoma Kinase, Human; NSCLC
Interventions: Drug: PF-02341066; Drug: Rifampin; Drug: Ketoconazole
Sponsors: Pfizer; Pfizer
Recruiting - verified May 2012 - Conditions: Brain and Central Nervous System Tumors; Breast Cancer; Cognitive/Functional Effects; Drug/Agent Toxicity by Tissue/Organ; Psychosocial Effects of Cancer and Its Treatment
Interventions: Biological: trastuzumab; Drug: carboplatin; Drug: methotrexate; Drug: sodium thiosulfate
Sponsors: OHSU Knight Cancer Institute; OHSU Knight Cancer Institute; National Cancer Institute (NCI)
Not yet recruiting - verified March 2012 - Condition: Brain and Central Nervous System Tumors
Interventions: Drug: Etoposide phosphate; Drug: Melphalan; Drug: Carboplatin; Drug: Sodium thiosulfate; Drug: Filgrastim; Drug: Pegfilgrastim
Sponsors: OHSU Knight Cancer Institute; OHSU Knight Cancer Institute; National Cancer Institute (NCI)
Recruiting - verified January 2012 - Conditions: Brain and Central Nervous System Tumors; Lymphoma
Interventions: Drug: Rituxan; Drug: Carboplatin; Drug: Methotrexate; Drug: Sodium thiosulfate; Drug: Neupogen; Drug: Neulasta; Drug: Leucovorin
Sponsors: OHSU Knight Cancer Institute; OHSU Knight Cancer Institute; National Cancer Institute (NCI)
Recruiting - verified January 2012 - Conditions: Phobic Disorders; Anxiety; Social Phobia
Intervention: Drug: D-Cycloserine
Sponsors: National Institutes of Health Clinical Center (CC); National Institute of Mental Health (NIMH)
Recruiting - verified December 2011 - Conditions: Low Back Pain; Pain
Interventions: Drug: D-cycloserine; Drug: placebo
Sponsors: Northwestern University; Thomas J. Schnitzer
Not yet recruiting - verified January 2012 - Conditions: Brain and Central Nervous System Tumors; Thrombocytopenia
Interventions: Drug: Carboplatin; Drug: Cyclophosphamide; Drug: Etoposide phosphate; Drug: Etoposide; Drug: Sodium thiosulfate
Sponsors: OHSU Knight Cancer Institute; OHSU Knight Cancer Institute; National Cancer Institute (NCI)
Recruiting - verified January 2012
 |
Antitubercular Agents Clinical Trials |
